These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16755049)

  • 1. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    El-Sherif ZA; Mohamed AO; El-Bardicy MG; El-Tarras MF
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):814-8. PubMed ID: 16755049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.
    Wahbi AA; Abdel-Razak O; Gazy AA; Mahgoub H; Moneeb MS
    J Pharm Biomed Anal; 2002 Nov; 30(4):1133-42. PubMed ID: 12408904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate.
    Moustafa AA
    J Pharm Biomed Anal; 2000 Feb; 22(1):45-58. PubMed ID: 10727122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.
    Chen F; He X; Fang B; Wang S
    Drug Des Devel Ther; 2020; 14():5689-5698. PubMed ID: 33380789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones.
    Rajab A; Touma M; Rudler H; Afonso C; Seuleiman M
    Pharmazie; 2013 Sep; 68(9):749-54. PubMed ID: 24147343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography.
    Ekpe A; Jacobsen T
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1057-65. PubMed ID: 10518247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.
    Noubarani M; Keyhanfar F; Motevalian M; Mahmoudian M
    J Pharm Pharm Sci; 2010; 13(1):1-10. PubMed ID: 20456825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole.
    Dixit S; Dubey R; Bhushan R
    Biomed Chromatogr; 2014 Jan; 28(1):112-9. PubMed ID: 23616104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of pantoprazole and its main impurities in pharmaceuticals.
    Letica J; Marković S; Zirojević J; Nikolić K; Agbaba D
    J AOAC Int; 2010; 93(4):1121-8. PubMed ID: 20922942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of lansoprazole in biological fluids and pharmaceutical dosage by HPLC.
    Avgerinos A; Karidas Th; Potsides C; Axarlis S
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):329-32. PubMed ID: 9725501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
    Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography.
    Karol MD; Granneman GR; Alexander K
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):182-6. PubMed ID: 7550976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
    World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.
    Aoki I; Okumura M; Yashiki T
    J Chromatogr; 1991 Nov; 571(1-2):283-90. PubMed ID: 1810958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
    Labenz J; Petersen KU; Rösch W; Koelz HR
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1015-9. PubMed ID: 12694083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets.
    Mohamed GG; Nour El-Dien FA; Khalil SM; El-Tantawy AS
    Drug Test Anal; 2010 Jan; 2(1):28-36. PubMed ID: 20878884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
    Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
    Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.